The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review
暂无分享,去创建一个
A. Green | A. Green | R. Will | C. Pennington | D. Everington | R. Knight | J. Mackenzie | G. Chohan | M. Andrews | J. MacKenzie
[1] P. Johannsen,et al. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease , 2009, Neurobiology of Aging.
[2] J Mackenzie,et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. , 2006, Brain : a journal of neurology.
[3] K. Eguchi,et al. 14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan , 2006, Cellular and Molecular Neurobiology.
[4] O. Simell,et al. The normal population distribution of PRNP codon 129 polymorphism , 2003, Acta neurologica Scandinavica.
[5] H. Budka,et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.
[6] J. Ironside,et al. Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[7] H. Budka,et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.
[8] A. Hofman,et al. Descriptive epidemiology of Creutzfeldt‐Jakob disease in six european countries, 1993–1995 , 1998, Annals of neurology.
[9] O. Gefeller,et al. Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.
[10] C. Gibbs,et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.
[11] Ritchie,et al. Clinical and Neuropathological Investigations in Creutzfeldt-Jakob Disease , 2022 .